title: Four-weekly infliximab in the treatment of severe hidradenitis suppurativa.
authors.affiliation: Department of Dermatology, King's College Hospital, Denmark Hill, London, SE5 9RS, U.K. blaithin.moriarty@gmail.com.
authors.forename: B
authors.initials: B
authors.lastname: Moriarty
authors.forename: Z
authors.initials: Z
authors.lastname: Jiyad
authors.forename: D
authors.initials: D
authors.lastname: Creamer
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D017497:Hidradenitis Suppurativa / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab